Pharming Group N.V.
PHGUF
$0.90
$0.1113.92%
Weiss Ratings | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Excellent | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.05 | |||
Price History | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 2.86% | |||
60-Day Total Return | -8.30% | |||
90-Day Total Return | 9.41% | |||
Year to Date Total Return | -8.30% | |||
1-Year Total Return | -25.00% | |||
2-Year Total Return | -28.57% | |||
3-Year Total Return | -5.26% | |||
5-Year Total Return | -15.09% | |||
52-Week High % Change | -15.49% | |||
52-Week Low % Change | 20.81% | |||
Price | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.07 | |||
52-Week Low Price | $0.75 | |||
52-Week Low Price (Date) | Nov 25, 2024 | |||
52-Week High Price (Date) | Apr 10, 2024 | |||
Valuation | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 548.91M | |||
Enterprise Value | 490.88M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | -95.02% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 2.79 | |||
Price/Book (Q) | 2.76 | |||
Enterprise Value/Revenue (TTM) | 2.52 | |||
Price | $0.90 | |||
Enterprise Value/EBITDA (TTM) | -136.56 | |||
Enterprise Value/EBIT | -33.92 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 688.98M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 31 71 524 7400 | |||
Address | -- | |||
Website | www.pharming.com | |||
Country | Netherlands | |||
Year Founded | 1988 | |||
Profitability | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $0.32 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | 34.97% | |||
Earnings Growth (Q YOY) | -192.34% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | -220.00% | |||
Balance Sheet | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 160.32M | |||
Cash Per Share (Q) | $0.23 | |||
Total Current Assets (Q) | 270.63M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 220.94M | |||
Current Ratio (Q) | 3.386 | |||
Book Value Per Share (Q) | $0.33 | |||
Total Assets (Q) | 415.93M | |||
Total Current Liabilities (Q) | 79.94M | |||
Total Debt (Q) | 122.02M | |||
Total Liabilities (Q) | 194.99M | |||
Total Common Equity (Q) | 220.94M | |||
Cash Flow | PHGUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||